CT found effective for Dx lung collapse in women
Using high-resolution CT scans to screen for lymphangioleiomyomatosis is cost-effective in women between the ages of 25 and 54 who don’t smoke and come to the emergency room for the first time with a collapsed lung, according to University of Cincinnati researchers.
Using high-resolution CT scans to screen for lymphangioleiomyomatosis is cost-effective in women between the ages of 25 and 54 who don’t smoke and come to the emergency room for the first time with a collapsed lung, according to University of Cincinnati researchers.
About 5% of women who fit the “model patient” profile-a 30-year old, nonsmoking woman who comes into the emergency room with a spontaneous lung collapse-test positive for lymphangioleiomyomatosis (LAM).
Screening for LAM with high-resolution CT is the most cost-effective strategy, with approximately $32,000 per quality-adjusted life year gained, the authors said. With this data, physicians will be able to intervene with therapies more quickly and enroll patients in clinical trials that may be able to slow progression of the disease.
The study will change future guideline recommendations on how to treat patients presenting with pneumothorax, according to Dr. John Heffner, past president of the American Thoracic Society.
The findings have been published online in the American Journal of Respiratory and Critical Care Medicine.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
